Cognitive-behavioral therapy for pathological gambling in parkinson's disease: A pilot controlled study

Susana Jiménez-Murcia, Francesca Isabella Bove, Mimi Israel, Howard Steiger, Fernando Fernández-Aranda, Eva Álvarez-Moya, Roser Granero, Eva Penelo, Begoña Vergé, Maria Neus Aymamí, Juan José Santamaría, Mónica Gómez-Peña, Laura Moragas, Lamprini G. Savvidou, José Manuel Menchón

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Abstract

Objectives: The main objective of this study was to compare the clinical characteristics and differences in response to treatment of two groups of pathological gamblers: with comorbid Parkinson's disease (PG + PD) and without (PG - PD). Methods: Clinical and psychopathological profiles and response to cognitive-behavioral treatment were assessed in 15 PG + PD and 45 PG - PD individuals consulting a specialized hospital Unit. Results: Statistically significant differences were observed between the two groups on a series of clinical variables. PG + PD patients were older and presented later onset of problematic gambling behaviors, lower alcohol consumption and higher bingo playing than PG - PD patients. No significant differences were noted in psychopathology except for lower measures of hostility in the PG + PD group. No statistical differences were detected between groups in terms of response to treatment. Conclusion: These results may provide guidance for obtaining accurate diagnostic information in pathological gamblers by properly identifying patients with specific needs that may be targeted with treatment. Copyright © 2012 S. Karger AG, Basel.
Original languageEnglish
Pages (from-to)265-274
JournalEuropean Addiction Research
Volume18
DOIs
Publication statusPublished - 1 Oct 2012

Keywords

  • Clinical features
  • Cognitive-behavioral therapy
  • Parkinson's disease
  • Pathological gambling
  • Therapy response

Fingerprint Dive into the research topics of 'Cognitive-behavioral therapy for pathological gambling in parkinson's disease: A pilot controlled study'. Together they form a unique fingerprint.

Cite this